Rhinegene Polandsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2022-09-13
Share capital
1 500 000,00 PLN
Activity description

Rhinegene Poland offers kits for testing related to sepsis, hepatitis and respiratory pathogens. Its instruments include the UNIO B24, UNIO 96 and UNIO B48 systems for automated nucleic acid extraction, including DNA and RNA.

Registered address
ul. Gdańska 47/49, 90-729 Łódź, Poland
Phone
Social media
Electronic delivery address
AE:PL-85641-51684-RIBIE-27

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 34 days early.

  • 2025filed
  • 202426/05/2025
  • 202327/06/2024
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 968.40kMedianUSD 1.06mAverageUSD 22.41m
Net profit
This companyUSD -498.86kMedianUSD 37.20kAverageUSD 879.46k
Operating costs
This companyUSD 1.32mMedianUSD 921.66kAverageUSD 21.08m
Assets
This companyUSD 924.71kMedianUSD 609.79kAverageUSD 11.85m

Industry

Offer

  • Sepsis diagnostic kits
  • Viral hepatitis diagnostic kits
  • Respiratory pathogen diagnostic kits
  • Laboratory instruments
  • Nucleic acid extraction systems
  • DNA and RNA extraction systems

Website technology

Online shop
  • WooCommerce
Website
  • WordPress
Analytics and marketing
  • Google Analytics

Public procurement

26 tenders recorded as contractor: 11 national ($249,671) and 15 EU ($972,722).

SubjectAmount
Supply of culture media, antibiotic discs and reagents for the microbiology laboratory, including lease of a blood and body fluid culture instrument and analyser
–
In vitro diagnostic medical devices supplied to direct recipients. Lots 1–2
$13,477
Supply of laboratory reagents
$8,104

Authorized Representatives

Alper Akyuz – Management Board Member
Elif Akyuz – Management Board Member

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Rhinegene B.v.
30,000$405,186.39100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2022-12-02.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Red Med Polandsp. z o.o.
Eumedsp. z o.o.
Genoplast BiotechS.A.
Gin-Medicalsp. z o.o.
Cytogen - Polskasp. z o.o.
Zbadajsiesp. z o.o.
Model MedicalS.A.
Farmatorsp. z o.o.
Polygensp. z o.o.
Semilabsp. z o.o.

Change history

DateEvent
2023-03-29Share capital change
2023-01-30Address change
2022-12-01Address change
2022-11-14Address change
2022-10-05Address change

FAQ

Last updated: 2026-10-07